Impact and consequences of intensive chemotherapy on intestinal barrier and microbiota in acute myeloid leukemia: the role of mucosal strengthening.


Journal

Gut microbes
ISSN: 1949-0984
Titre abrégé: Gut Microbes
Pays: United States
ID NLM: 101495343

Informations de publication

Date de publication:
09 11 2020
Historique:
entrez: 7 9 2020
pubmed: 8 9 2020
medline: 1 10 2021
Statut: ppublish

Résumé

Induction chemotherapy (7 + 3 regimen) remains the gold standard for patients with acute myeloid leukemia (AML) but is responsible for gut damage leading to several complications such as bloodstream infection (BSI). We aimed to investigate the impact of induction chemotherapy on the intestinal barrier of patients with AML and in wild-type mice. Next, we assessed the potential benefit of strengthening the mucosal barrier in transgenic mice releasing a recombinant protein able to reinforce the mucus layer (Tg222). In patients, we observed a decrease of plasma citrulline, which is a marker of the functional enterocyte mass, of short-chain fatty acids and of fecal bacterial load, except for

Identifiants

pubmed: 32893715
doi: 10.1080/19490976.2020.1800897
pmc: PMC7524297
doi:

Substances chimiques

Fatty Acids, Volatile 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1800897

Références

Biol Blood Marrow Transplant. 2018 Nov;24(11):2190-2196
pubmed: 30454871
Pediatr Blood Cancer. 2009 Dec 15;53(7):1188-94
pubmed: 19688831
Bone Marrow Transplant. 2008 Sep;42(5):345-9
pubmed: 18587437
PLoS One. 2010 Dec 20;5(12):e15156
pubmed: 21188146
Proc Nutr Soc. 2003 Feb;62(1):67-72
pubmed: 12740060
Appl Environ Microbiol. 1997 Jul;63(7):2802-13
pubmed: 9212428
Gut Microbes. 2011 Mar-Apr;2(2):99-104
pubmed: 21694499
Infect Immun. 2003 May;71(5):2839-58
pubmed: 12704158
Br J Nutr. 2008 Dec;100(6):1251-9
pubmed: 18466653
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Transplantation. 2012 Aug 15;94(3):287-94
pubmed: 22785249
Biol Blood Marrow Transplant. 2017 Jun;23(6):913-921
pubmed: 28263922
Infect Dis (Lond). 2017 Nov - Dec;49(11-12):799-808
pubmed: 28683646
Biol Blood Marrow Transplant. 2008 Sep;14(9):1017-1021
pubmed: 18721764
mSystems. 2017 Mar 7;2(2):
pubmed: 28289733
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
J Clin Invest. 2010 Dec;120(12):4332-41
pubmed: 21099116
PLoS One. 2011 Apr 12;6(4):e18761
pubmed: 21533274
Blood. 2013 Mar 21;121(12):e90-7
pubmed: 23349390
Sci Rep. 2015 May 14;5:9577
pubmed: 25974250
Cancer. 2005 Jan 1;103(1):191-9
pubmed: 15573372
Gastroenterol Rep (Oxf). 2019 Feb;7(1):3-12
pubmed: 30792861
Cancer. 2016 Jul 15;122(14):2186-96
pubmed: 27142181
Clin Gastroenterol Hepatol. 2018 Jun;16(6):908-917.e2
pubmed: 29258901
Br J Nutr. 2008 Aug;100(2):297-305
pubmed: 18346306
Clin Nutr. 2008 Jun;27(3):328-39
pubmed: 18440672
Bone Marrow Transplant. 2012 Sep;47(9):1191-5
pubmed: 22231466
Tissue Barriers. 2017 Jan 2;5(1):e1274354
pubmed: 28452685
Bioinformatics. 2012 Oct 1;28(19):2520-2
pubmed: 22908215
Oncogene. 2016 Jun 2;35(22):2842-51
pubmed: 26364610
Transplantation. 2006 Sep 27;82(6):835-9
pubmed: 17006332
Gastroenterology. 2000 Dec;119(6):1496-505
pubmed: 11113071
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
BMC Biol. 2013 May 21;11:61
pubmed: 23692866
PLoS One. 2013;8(1):e54335
pubmed: 23372709
Aliment Pharmacol Ther. 2015 Sep;42(5):515-28
pubmed: 26147207
Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):352-61
pubmed: 23478383
N Engl J Med. 2004 Dec 16;351(25):2590-8
pubmed: 15602019
N Engl J Med. 2020 Feb 27;382(9):822-834
pubmed: 32101664
JIMD Rep. 2014;13:119-28
pubmed: 24190798
Sci Transl Med. 2016 May 18;8(339):339ra71
pubmed: 27194729
Int J Clin Exp Pathol. 2014 Jul 15;7(8):4557-76
pubmed: 25197329
Appl Environ Microbiol. 2005 Dec;71(12):8228-35
pubmed: 16332807
Nat Methods. 2013 Jan;10(1):57-9
pubmed: 23202435
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Ann Oncol. 2010 Aug;21(8):1706-1711
pubmed: 20089560
PLoS One. 2017 May 19;12(5):e0178059
pubmed: 28542412
Sci Rep. 2015 Nov 04;5:16094
pubmed: 26531327
Appl Environ Microbiol. 2007 Mar;73(5):1576-85
pubmed: 17220268
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Clin Nutr. 2018 Dec;37(6 Pt A):2113-2121
pubmed: 29097037
Cell Host Microbe. 2017 Jan 11;21(1):7-10
pubmed: 28081445
J Clin Oncol. 2017 Aug 20;35(24):2754-2763
pubmed: 28632487
Cell Host Microbe. 2016 Apr 13;19(4):443-54
pubmed: 27078066
Nature. 2013 Dec 19;504(7480):446-50
pubmed: 24226770
Nat Immunol. 2016 May;17(5):505-513
pubmed: 26998764
Am J Physiol Gastrointest Liver Physiol. 2016 Feb 15;310(4):G225-7
pubmed: 26660538
Sci Rep. 2019 Nov 18;9(1):16993
pubmed: 31740753
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Genes Dev. 2009 Apr 1;23(7):877-89
pubmed: 19339691
Mucosal Immunol. 2014 May;7(3):589-601
pubmed: 24129165
Genome Med. 2016 Apr 28;8(1):49
pubmed: 27121964

Auteurs

Thomas Hueso (T)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille, France.

Kenneth Ekpe (K)

Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay , Jouy-en-Josas, France.

Camille Mayeur (C)

Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay , Jouy-en-Josas, France.

Anna Gatse (A)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille, France.

Marie Joncquel-Chevallier Curt (M)

Department of Biochemistry, CHU Lille , Lille, France.

Guillaume Gricourt (G)

NGS Platform, IMRB, CHU Henri Mondor , Créteil, France.
Institut Mondor de Recherche Biomédicale, Inserm U955 , Créteil, France.

Christophe Rodriguez (C)

NGS Platform, IMRB, CHU Henri Mondor , Créteil, France.
Institut Mondor de Recherche Biomédicale, Inserm U955 , Créteil, France.

Charles Burdet (C)

School of Medicine, EA3964 University of Paris Diderot, Sorbonne Paris Cité , Paris, France.

Guillaume Ulmann (G)

Department of Biochemistry, Cochin Hospital - HUPC , Paris, France.

Christel Neut (C)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille, France.

Salah-Eddine Amini (SE)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille, France.

Patricia Lepage (P)

Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay , Jouy-en-Josas, France.

Bruno Raynard (B)

Nutrition Department, Gustave Roussy Cancer Centre, F-94805 , Villejuif, France.

Christophe Willekens (C)

Hematology Departement, Gustave Roussy Cancer Centre, F-94805 , Villejuif, France.

Jean-Baptiste Micol (JB)

Hematology Departement, Gustave Roussy Cancer Centre, F-94805 , Villejuif, France.

Stéphane De Botton (S)

Hematology Departement, Gustave Roussy Cancer Centre, F-94805 , Villejuif, France.

Ibrahim Yakoub-Agha (I)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille, France.
Allogeneic Stem Cell Department, CHU Lille, Lille, France.

Frédéric Gottrand (F)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille, France.

Jean-Luc Desseyn (JL)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille, France.

Muriel Thomas (M)

Micalis Institute, INRAE, AgroParisTech, Université Paris-Saclay , Jouy-en-Josas, France.

Paul-Louis Woerther (PL)

Department of Microbiology and Infection Control, Henri-Mondor Hospital , Créteil, France.
EA 7380 Dynamyc, EnvA, UPEC, Paris-Est University , Créteil, France.

David Seguy (D)

Univ. Lille, Inserm, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation , Lille, France.
Nutrition Unit, CHU Lille , Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH